2023
Entrant
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant
Marsden Marketing
Category
Website - Business to Business
Country / Region
United States
Entrant
Budder Creative
Category
Corporate Identity - Logos
Country / Region
United States
Entrant
Sparq Designs
Category
Marketing & Promotional - Illustration
Country / Region
United States